CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 980542593
- Phone
- (877) 237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-05 | BAKER BROS. ADVISORS LP Director | Option exercise | +57,049 | 155,874 | ||
| 2023-10-05 | BAKER BROS. ADVISORS LP Director | Option exercise | +535,601 | 1,658,190 | ||
| 2023-10-05 | BAKER BROS. ADVISORS LP Director | Option exercise · Pre-funded Warrants | −57,049 | 182,775 | ||
| 2023-10-05 | BAKER BROS. ADVISORS LP Director | Option exercise · Pre-funded Warrants | −535,601 | 1,521,176 | ||
| 2023-08-17 | BAKER BROS. ADVISORS LP Director | Purchase | +7,676 | $0.69 | $5K | 489,092 |
| 2023-08-17 | BAKER BROS. ADVISORS LP Director | Purchase | +93,091 | $0.69 | $64K | 5,551,815 |
| 2023-08-17 | BAKER BROS. ADVISORS LP Director | Purchase | +5,041 | $0.69 | $3K | 494,133 |
| 2023-08-17 | BAKER BROS. ADVISORS LP Director | Purchase | +61,134 | $0.69 | $42K | 5,612,949 |
| 2023-08-16 | BAKER BROS. ADVISORS LP Director | Purchase | +17,124 | $0.68 | $12K | 481,050 |
| 2023-08-16 | BAKER BROS. ADVISORS LP Director | Purchase | +207,676 | $0.68 | $141K | 5,454,290 |
| 2023-08-16 | BAKER BROS. ADVISORS LP Director | Purchase | +366 | $0.68 | $250 | 481,416 |
| 2023-08-16 | BAKER BROS. ADVISORS LP Director | Purchase | +4,434 | $0.68 | $3K | 5,458,724 |
| 2023-08-15 | BAKER BROS. ADVISORS LP Director | Purchase | +143,519 | $0.63 | $91K | 463,568 |
| 2023-08-15 | BAKER BROS. ADVISORS LP Director | Purchase | +1,740,581 | $0.63 | $1.1M | 5,242,272 |
| 2023-08-15 | BAKER BROS. ADVISORS LP Director | Purchase | +358 | $0.67 | $238 | 463,926 |
| 2023-08-15 | BAKER BROS. ADVISORS LP Director | Purchase | +4,342 | $0.67 | $3K | 5,246,614 |
| 2023-08-11 | Smith Sean Michael Interim CFO, Prin Acct Off | Sale | −1,323 | $0.62 | $818 | 21,637 |
| 2023-08-10 | Smith Sean Michael Interim CFO, Prin Acct Off | Option exercise | +5,000 | 22,960 | ||
| 2023-08-10 | Smith Sean Michael Interim CFO, Prin Acct Off | Option exercise · Restricted Stock Units | −5,000 | 0 | ||
| 2023-06-08 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 |
Page 5 of 8 · 158 trades